Overview
Imaging evaluates extent nodal involvement and metastatic disease in gynecologic malignancies. Modalities include ultrasound CT MRI and PET CT. Imaging guides surgical planning and adjuvant therapy decisions.
Pelvic MRI
MRI provides superior soft tissue contrast for local staging of cervical and endometrial cancers. It assesses tumor size parametrial invasion and nodal status. Standardized reporting improves multidisciplinary communication.
PET CT Role
PET CT detects nodal and distant metastatic disease in selected gynecologic cancers. It aids in recurrence detection and treatment planning. Tracer selection and timing influence sensitivity.
Surveillance and Recurrence
Imaging protocols for surveillance depend on tumor type stage and treatment. Early detection of recurrence may influence salvage therapy options. Multidisciplinary review ensures appropriate imaging intervals and modalities.